Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
9
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Post-nasal Drip
View Full LandscapeNo patent data available. Pre-approval drugs may not have Orange Book listings.
Desloratadine ratiopharm
Desloratadine ratiopharm is indicated in adults for the relief of symptoms associated with: allergic rhinitis chronic idiopathic urticaria as initially diagnosed by a physician
View on EMADasselta
Dasselta is indicated for the relief of symptoms associated with: allergic rhinitis; urticaria.
View on EMADesloratadine Teva
Desloratadine Teva is indicated for the relief of symptoms associated with: allergic rhinitis; urticaria.
View on EMAAllex
Aerius is indicated for the relief of symptoms associated with: allergic rhinitis (see section 5.1) urticaria (see section 5.1)
View on EMAOpulis
Opulis is indicated for the relief of symptoms associated with:- allergic rhinitis (see section 5.1)- urticaria (see section 5.1)
View on EMANeoclarityn
Neoclarityn is indicated for the relief of symptoms associated with: allergic rhinitis urticaria
View on EMAAzomyr
Azomyr is indicated for the relief of symptoms associated with: allergic rhinitis (see section 5.1) urticaria (see section 5.1)
View on EMA